REGENXBIO (RGNX) News Today $9.63 -1.51 (-13.55%) (As of 11/15/2024 ET) Add Compare Share Share Headlines Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSustainabilityTrends All Sources Trusted Sources MarketBeat.com Benzinga Bloomberg GuruFocus MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha The Street TipRanks The Wall Street Journal Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative Most Recent November 2024 October 2024 September 2024 August 2024 July 2024 June 2024 May 2024 April 2024 March 2024 February 2024 January 2024 December 2023 November 2023 October 2023 September 2023 August 2023 July 2023 June 2023 May 2023 April 2023 March 2023 February 2023 January 2023 December 2022 November 2022 October 2022 September 2022 August 2022 July 2022 June 2022 May 2022 April 2022 March 2022 February 2022 January 2022 December 2021 Time Period REGENXBIO Inc. (NASDAQ:RGNX) Given Consensus Recommendation of "Moderate Buy" by BrokeragesREGENXBIO Inc. (NASDAQ:RGNX - Get Free Report) has earned an average rating of "Moderate Buy" from the twelve ratings firms that are presently covering the stock, MarketBeat Ratings reports. One research analyst has rated the stock with a hold recommendation and eleven have issued a buy recommendNovember 17 at 1:47 AM | marketbeat.comOptimistic Growth Potential for RegenXBio Amidst Delivery Challenges and Promising Gene Therapy AdvancesNovember 16 at 2:58 AM | markets.businessinsider.comRegenxbio assumed with an Overweight at Morgan StanleyNovember 16 at 2:58 AM | markets.businessinsider.comREGENXBIO (NASDAQ:RGNX) Shares Gap Up - What's Next?REGENXBIO (NASDAQ:RGNX) Shares Gap Up - Still a Buy?November 15 at 12:19 PM | marketbeat.comREGENXBIO's (RGNX) Overweight Rating Reaffirmed at Morgan StanleyMorgan Stanley reaffirmed an "overweight" rating and issued a $22.00 price target on shares of REGENXBIO in a report on Friday.November 15 at 8:30 AM | marketbeat.comREGENXBIO to Host Webcast Discussing Pivotal Program and First Functional Data from the AFFINITY DUCHENNE® Trial of RGX-202November 14 at 7:05 AM | prnewswire.comLeerink Partnrs Decreases Earnings Estimates for REGENXBIONovember 13, 2024 | americanbankingnews.comHC Wainwright Has Positive View of REGENXBIO FY2024 EarningsNovember 12, 2024 | americanbankingnews.comHC Wainwright Issues Positive Forecast for REGENXBIO (NASDAQ:RGNX) Stock PriceNovember 11, 2024 | americanbankingnews.comHC Wainwright Increases Earnings Estimates for REGENXBIOREGENXBIO Inc. (NASDAQ:RGNX - Free Report) - Research analysts at HC Wainwright upped their FY2024 EPS estimates for shares of REGENXBIO in a report released on Thursday, November 7th. HC Wainwright analyst Y. Chen now expects that the biotechnology company will post earnings per share of ($4.92)November 11, 2024 | marketbeat.comREGENXBIO FY2024 EPS Estimate Reduced by Leerink PartnrsREGENXBIO Inc. (NASDAQ:RGNX - Free Report) - Investment analysts at Leerink Partnrs reduced their FY2024 EPS estimates for REGENXBIO in a research report issued to clients and investors on Wednesday, November 6th. Leerink Partnrs analyst M. Foroohar now anticipates that the biotechnology companyNovember 11, 2024 | marketbeat.comAnalysts Have Made A Financial Statement On REGENXBIO Inc.'s (NASDAQ:RGNX) Third-Quarter ReportNovember 9, 2024 | finance.yahoo.comPromising Advancements and Key Catalysts Drive Buy Rating for RegenXBioNovember 8, 2024 | markets.businessinsider.comAnalysts Conflicted on These Healthcare Names: RegenXBio (RGNX), Gossamer Bio (GOSS) and Monte Rosa Therapeutics (GLUE)November 8, 2024 | markets.businessinsider.comRegenXBio’s Promising Gene Therapy Advancements and Strategic Financial Growth: A Buy RecommendationNovember 8, 2024 | markets.businessinsider.comStifel Nicolaus Sticks to Its Buy Rating for RegenXBio (RGNX)November 8, 2024 | markets.businessinsider.comREGENXBIO (NASDAQ:RGNX) Shares Gap Up - Here's WhyREGENXBIO (NASDAQ:RGNX) Shares Gap Up - Here's What HappenedNovember 7, 2024 | marketbeat.comRegenxbio Inc (RGNX) Q3 2024 Earnings Call Highlights: Advancements in Gene Therapy and ...November 7, 2024 | sg.finance.yahoo.comRegenxbio sees cash and securities sufficient into 2026November 7, 2024 | markets.businessinsider.comREGENXBIO Inc. (RGNX) Q3 2024 Earnings Call TranscriptNovember 7, 2024 | seekingalpha.comREGENXBIO Reports Third Quarter 2024 Financial Results and Recent Operational UpdatesNovember 6, 2024 | prnewswire.comRegenxbio Inc (RGNX) Q3 2024: Everything You Need To Know Ahead Of EarningsNovember 5, 2024 | finance.yahoo.comREGENXBIO to Participate in Upcoming Investor ConferencesNovember 4, 2024 | prnewswire.comREGENXBIO (RGNX) Set to Announce Quarterly Earnings on WednesdayREGENXBIO (NASDAQ:RGNX) will be releasing earnings after the market closes on Wednesday, November 6, Zacks reports.October 31, 2024 | marketbeat.comREGENXBIO to Host Conference Call on November 6 to Discuss Third Quarter 2024 Financial Results and Recent Operational HighlightsOctober 30, 2024 | prnewswire.comAssenagon Asset Management S.A. Cuts Stock Holdings in REGENXBIO Inc. (NASDAQ:RGNX)Assenagon Asset Management S.A. lessened its holdings in REGENXBIO Inc. (NASDAQ:RGNX - Free Report) by 31.4% in the 3rd quarter, according to its most recent filing with the SEC. The firm owned 559,872 shares of the biotechnology company's stock after selling 256,512 shares during the period. AssenOctober 30, 2024 | marketbeat.comThe past five years for REGENXBIO (NASDAQ:RGNX) investors has not been profitableOctober 24, 2024 | uk.finance.yahoo.comREGENXBIO Inc. (NASDAQ:RGNX) Given Average Rating of "Moderate Buy" by BrokeragesREGENXBIO Inc. (NASDAQ:RGNX - Get Free Report) has earned a consensus recommendation of "Moderate Buy" from the twelve ratings firms that are presently covering the company, Marketbeat.com reports. Two analysts have rated the stock with a hold rating and ten have issued a buy rating on the companOctober 23, 2024 | marketbeat.comREGENXBIO (NASDAQ:RGNX) Earns Buy Rating from Chardan CapitalChardan Capital reaffirmed a "buy" rating and issued a $52.00 price target on shares of REGENXBIO in a research note on Tuesday.October 22, 2024 | marketbeat.comREGENXBIO (NASDAQ:RGNX) Trading Down 6.4% - Time to Sell?REGENXBIO (NASDAQ:RGNX) Stock Price Down 6.4% - Here's What HappenedOctober 21, 2024 | marketbeat.comRegenxbio presents positive Phase 2 data of ABBV-RGX-314 in wet AMDOctober 21, 2024 | markets.businessinsider.comREGENXBIO Presents Positive Data from the Phase II Study of Subretinal ABBV-RGX-314 in Patients with Bilateral Wet AMD at AAO 2024October 21, 2024 | prnewswire.comREGENXBIO Announces Presentations at the American Academy of Ophthalmology 2024 Annual MeetingOctober 18, 2024 | prnewswire.comREGENXBIO (NASDAQ:RGNX) Stock Price Up 6.6% - Still a Buy?REGENXBIO (NASDAQ:RGNX) Trading 6.6% Higher - Here's What HappenedOctober 16, 2024 | marketbeat.comStifel Nicolaus Remains a Buy on RegenXBio (RGNX)October 15, 2024 | markets.businessinsider.comMillennium Management LLC Has $3.59 Million Position in REGENXBIO Inc. (NASDAQ:RGNX)Millennium Management LLC grew its position in REGENXBIO Inc. (NASDAQ:RGNX - Free Report) by 84.8% during the 2nd quarter, according to the company in its most recent disclosure with the SEC. The firm owned 306,487 shares of the biotechnology company's stock after purchasing an additional 140,666 sOctober 14, 2024 | marketbeat.com3 Best Stocks to Buy Now, 10/11/2024, According to Top AnalystsOctober 11, 2024 | msn.comDimensional Fund Advisors LP Has $12.96 Million Stock Position in REGENXBIO Inc. (NASDAQ:RGNX)Dimensional Fund Advisors LP cut its position in REGENXBIO Inc. (NASDAQ:RGNX - Free Report) by 7.5% during the second quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The institutional investor owned 1,107,453 shares of the biotechnologOctober 6, 2024 | marketbeat.comSquarepoint Ops LLC Boosts Stock Position in REGENXBIO Inc. (NASDAQ:RGNX)Squarepoint Ops LLC raised its stake in REGENXBIO Inc. (NASDAQ:RGNX - Free Report) by 630.9% during the 2nd quarter, according to its most recent filing with the Securities and Exchange Commission. The fund owned 146,259 shares of the biotechnology company's stock after purchasing an additional 126October 5, 2024 | marketbeat.comArgeris N. Karabelas Sells 10,000 Shares of REGENXBIO Inc. (NASDAQ:RGNX) StockOctober 3, 2024 | insidertrades.comCubist Systematic Strategies LLC Buys 79,655 Shares of REGENXBIO Inc. (NASDAQ:RGNX)Cubist Systematic Strategies LLC increased its stake in shares of REGENXBIO Inc. (NASDAQ:RGNX - Free Report) by 73.4% during the 2nd quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission (SEC). The fund owned 188,235 shares of the biotechnologyOctober 1, 2024 | marketbeat.comREGENXBIO Inc. (NASDAQ:RGNX) Receives Average Recommendation of "Moderate Buy" from AnalystsShares of REGENXBIO Inc. (NASDAQ:RGNX - Get Free Report) have been given an average rating of "Moderate Buy" by the twelve analysts that are covering the stock, Marketbeat Ratings reports. Two research analysts have rated the stock with a hold rating and ten have issued a buy rating on the companSeptember 28, 2024 | marketbeat.comREGENXBIO to Participate in Chardan's 8th Annual Genetic Medicines ConferenceSeptember 23, 2024 | prnewswire.comREGENXBIO Inc. (NASDAQ:RGNX) Shares Bought by Integral Health Asset Management LLCIntegral Health Asset Management LLC boosted its holdings in shares of REGENXBIO Inc. (NASDAQ:RGNX - Free Report) by 25.0% in the second quarter, according to its most recent disclosure with the Securities and Exchange Commission (SEC). The firm owned 950,000 shares of the biotechnology company's sSeptember 23, 2024 | marketbeat.comRGNX Jan 2025 20.000 callSeptember 21, 2024 | ca.finance.yahoo.comRGNX Oct 2024 22.500 callSeptember 21, 2024 | ca.finance.yahoo.comStockNews.com Upgrades REGENXBIO (NASDAQ:RGNX) to "Hold"StockNews.com raised shares of REGENXBIO from a "sell" rating to a "hold" rating in a report on Friday.September 20, 2024 | marketbeat.comAcadian Asset Management LLC Invests $494,000 in REGENXBIO Inc. (NASDAQ:RGNX)Acadian Asset Management LLC bought a new position in REGENXBIO Inc. (NASDAQ:RGNX - Free Report) during the second quarter, according to its most recent filing with the Securities and Exchange Commission. The fund bought 42,292 shares of the biotechnology company's stock, valued at approximately $4September 19, 2024 | marketbeat.comREGENXBIO Appoints Mitchell Chan as Chief Financial OfficerSeptember 17, 2024 | prnewswire.comREGENXBIO Inc. (NASDAQ:RGNX) Shares Acquired by Quest Partners LLCQuest Partners LLC lifted its position in shares of REGENXBIO Inc. (NASDAQ:RGNX - Free Report) by 11,731.0% during the 2nd quarter, according to its most recent disclosure with the SEC. The firm owned 42,000 shares of the biotechnology company's stock after buying an additional 41,645 shares duringSeptember 13, 2024 | marketbeat.com Get REGENXBIO News Delivered to You Automatically Sign up to receive the latest news and ratings for RGNX and its competitors with MarketBeat's FREE daily newsletter. Email Address Strange: Why is Amazon suddenly yielding 39.70%? (Ad)Something big is happening with Amazon stock… While most investors collect ZERO dividends from Amazon… A small group just discovered a "backdoor" way to collect yields up to 39.70%! Click here to see this breakthrough before everyone else → RGNX Media Mentions By Week RGNX Media Sentiment Learn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. RGNX News Sentiment▼0.390.55▲Average Medical News Sentiment RGNX News Coverage Learn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. RGNX Articles This Week▼194▲RGNX Articles Average Week Get REGENXBIO News Delivered to You Automatically Sign up to receive the latest news and ratings for RGNX and its competitors with MarketBeat's FREE daily newsletter. Email Address Related Companies and Tools Related Companies SGMO News CCCC News ALEC News QURE News BDTX News CGEN News BLUE News GLPG News TARS News WVE News Headlines Tools Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (NASDAQ:RGNX) was last updated on 11/17/2024 by MarketBeat.com Staff From Our PartnersBill Gates’s Next Big AI Bet: StargateIn February 2016… when almost nobody was talking about artificial intelligence…. I picked Nvidia as one of ...Brownstone Research | SponsoredThe Crypto That’s Making Wall Street SweatThe Crypto Wall Street Is Desperate to Hide It's happening now, right under everyone's radar. Big tech gian...Crypto 101 Media | SponsoredThere is a little known company that is changing warfareWith geo - political instability around the world investors are flocking to defense contract stocks. There...Reticulate | SponsoredTim Sykes’ Urgent Trade Alert: “Make this move now”WARNING: 80 Wall Street banks are gearing up for MASSIVE D.C. shock This $2 trillion D.C. shock is NOT abou...Timothy Sykes | SponsoredElon knows the truth, which is why they want him silencedElon Musk is one of mankind’s greatest innovators. But for all his visionary prowess and contributions to h...Porter & Company | Sponsored24/7 Automated Profits in CryptoWhat if you could make consistent daily profits in crypto with minimal effort? Beyond trading lies a vast w...Crypto Swap Profits | SponsoredTrump Wins… But Elon Says Get Ready to BraceTrump's back in the White House, ready to hit the gas on America's comeback. He's taking on the economy wi...Genesis Gold Group | SponsoredUnveiled: NVIDIA’s "Secret Royalty" ProgramDid you know that there's an investment that will give you the opportunity to collect "royalties" every time N...Behind the Markets | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding REGENXBIO Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share REGENXBIO With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Free RGNX Stock Alerts